1. Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection. Issue 1 (20th October 2020) Authors: Takaoka, Yoshinari; Miura, Kouichi; Morimoto, Naoki; Ikegami, Tadashi; Kakizaki, Satoru; Sato, Ken; Ueno, Takashi; Naganuma, Atsushi; Kosone, Takashi; Arai, Hirotaka; Hatanaka, Takeshi; Tahara, Toshiyuki; Tano, Shigeo; Ohtake, Takaaki; Murohisa, Toshimitsu; Namikawa, Masashi; Asano, Takeharu; Kam... Journal: Hepatology research Issue: Volume 51:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection. Issue 1 (20th October 2020) Authors: Takaoka, Yoshinari; Miura, Kouichi; Morimoto, Naoki; Ikegami, Tadashi; Kakizaki, Satoru; Sato, Ken; Ueno, Takashi; Naganuma, Atsushi; Kosone, Takashi; Arai, Hirotaka; Hatanaka, Takeshi; Tahara, Toshiyuki; Tano, Shigeo; Ohtake, Takaaki; Murohisa, Toshimitsu; Namikawa, Masashi; Asano, Takeharu; Kam... Journal: Hepatology research Issue: Volume 51:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗